CLDI
Price
$1.60
Change
+$0.03 (+1.91%)
Updated
Sep 5 closing price
Capitalization
8.4M
RXRX
Price
$4.61
Change
+$0.09 (+1.99%)
Updated
Sep 5 closing price
Capitalization
2.01B
60 days until earnings call
Interact to see
Advertisement

CLDI vs RXRX

Header iconCLDI vs RXRX Comparison
Open Charts CLDI vs RXRXBanner chart's image
Calidi Biotherapeutics
Price$1.60
Change+$0.03 (+1.91%)
Volume$245.04K
Capitalization8.4M
Recursion Pharmaceuticals
Price$4.61
Change+$0.09 (+1.99%)
Volume$13.76M
Capitalization2.01B
CLDI vs RXRX Comparison Chart in %
Loading...
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLDI vs. RXRX commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLDI is a Hold and RXRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CLDI: $1.60 vs. RXRX: $4.61)
Brand notoriety: CLDI and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLDI: 12% vs. RXRX: 59%
Market capitalization -- CLDI: $8.4M vs. RXRX: $2.01B
CLDI [@Biotechnology] is valued at $8.4M. RXRX’s [@Biotechnology] market capitalization is $2.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLDI’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • CLDI’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLDI and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLDI’s TA Score shows that 3 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • CLDI’s TA Score: 3 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CLDI is a better buy in the short-term than RXRX.

Price Growth

CLDI (@Biotechnology) experienced а -3.03% price change this week, while RXRX (@Biotechnology) price change was -1.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.01B) has a higher market cap than CLDI($8.4M). RXRX YTD gains are higher at: -31.805 vs. CLDI (-88.406). CLDI has higher annual earnings (EBITDA): -17.92M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. CLDI (5.28M). CLDI has less debt than RXRX: CLDI (4.01M) vs RXRX (88.1M). RXRX has higher revenues than CLDI: RXRX (64.5M) vs CLDI (0).
CLDIRXRXCLDI / RXRX
Capitalization8.4M2.01B0%
EBITDA-17.92M-583.64M3%
Gain YTD-88.406-31.805278%
P/E RatioN/AN/A-
Revenue064.5M-
Total Cash5.28M525M1%
Total Debt4.01M88.1M5%
TECHNICAL ANALYSIS
Technical Analysis
CLDIRXRX
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 25 days ago
51%
Bullish Trend 16 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CLDI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJIZX9.54N/A
N/A
PGIM Quant Solutions International Eq Z
FDIVX49.84N/A
N/A
Fidelity Diversified International
AABCX16.40N/A
N/A
Putnam Dynamic Asset Allocation Bal C
NGCAX41.75N/A
N/A
Columbia Greater China A
EPSIX24.87N/A
N/A
NYLI Epoch Global Equity Yield Inv Class

CLDI and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLDI has been loosely correlated with ORYZF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CLDI jumps, then ORYZF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLDI
1D Price
Change %
CLDI100%
+1.91%
ORYZF - CLDI
37%
Loosely correlated
N/A
DYN - CLDI
33%
Poorly correlated
+7.40%
RYTM - CLDI
31%
Poorly correlated
-2.34%
DSGN - CLDI
30%
Poorly correlated
+5.56%
RXRX - CLDI
29%
Poorly correlated
+1.99%
More